Literature DB >> 28238415

The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.

Jane E Armes1, Christine Galbraith2, Janet Gray2, Kathleen Taylor2.   

Abstract

Papillary lesions of the breast are most commonly diagnosed via mammographic screening. The standard practice has been to excise these lesions, since a subset of papillary lesions are neoplastic. However, this approach leads to a high proportion of negative excisions. In order to identify papillary lesions which could be managed by surveillance alone, we assessed the outcome of 103 papillary lesions diagnosed on core needle biopsy in a public screening program. Subsequent excision biopsy led to an upgrade to malignancy in 30% of cases. Segregation via presence or absence of atypia stratified the outcome into 72% upgrade, compared with 7% upgrade, respectively. Further, in the latter group (i.e., no atypia on core needle biopsy with 7% upgrade to malignancy), the neoplasia found in the targeted excision area was low to intermediate grade ductal carcinoma in situ only, with no invasive neoplasia (4 cases). Of the lesions identified due to microcalcification, the microcalcification was present within an adjacent benign lesion in 35% of cases and hence the papillary lesion was detected incidentally. Overall therefore, we have identified a cohort of papillary lesions in which conservative management, rather than excision, could be considered, i.e., those without atypia, including those without atypia in which the papillary lesion was found incidental to microcalcification in an adjacent benign lesion.
Copyright © 2017 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intraduct papilloma; core needle biopsy; ductal carcinoma in situ; mammographic screening; papillary carcinoma; papillary hyperplasia; papillary lesion of breast

Mesh:

Year:  2017        PMID: 28238415     DOI: 10.1016/j.pathol.2016.12.346

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

Review 1.  How Do We Approach Benign Proliferative Lesions?

Authors:  Faina Nakhlis
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

2.  Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision.

Authors:  Christine MacColl; Amir Salehi; Sameer Parpia; Nicole Hodgson; Milita Ramonas; Phillip Williams
Journal:  Virchows Arch       Date:  2019-08-01       Impact factor: 4.064

3.  Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.

Authors:  Xiaoli Zhang; Wenqing Liu; Tao Hai; Fei Li
Journal:  Ann Surg Oncol       Date:  2021-07-30       Impact factor: 5.344

4.  A papilloma in a large cyst of the breast: A case report.

Authors:  Hwan Soo Kim; Yang Hei Kim; Sung Bae Park
Journal:  Int J Surg Case Rep       Date:  2018-11-16

Review 5.  Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Authors:  Christoph J Rageth; Elizabeth A M O'Flynn; Katja Pinker; Rahel A Kubik-Huch; Alexander Mundinger; Thomas Decker; Christoph Tausch; Florian Dammann; Pascal A Baltzer; Eva Maria Fallenberg; Maria P Foschini; Sophie Dellas; Michael Knauer; Caroline Malhaire; Martin Sonnenschein; Andreas Boos; Elisabeth Morris; Zsuzsanna Varga
Journal:  Breast Cancer Res Treat       Date:  2018-11-30       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.